{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:44:39Z","timestamp":1792201479644,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["UL1RR024986"],"award-info":[{"award-number":["UL1RR024986"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.06.063","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T05:42:32Z","timestamp":1342158152000},"page":"396-402","source":"Crossref","is-referenced-by-count":144,"special_numbering":"C","title":["Cannabinoid facilitation of fear extinction memory recall in humans"],"prefix":"10.1016","volume":"64","author":[{"given":"Christine A.","family":"Rabinak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Angstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra S.","family":"Sripada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Abelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Liberzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed R.","family":"Milad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Luan","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.06.063_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.psc.2009.05.001","article-title":"First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives","volume":"32","author":"Arch","year":"2009","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(02)01546-9","article-title":"Context, ambiguity, and unlearning: sources of relapse after behavioral extinction","volume":"52","author":"Bouton","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.biopsych.2005.12.015","article-title":"Contextual and temporal modulation of extinction: behavioral and biological mechanisms","volume":"60","author":"Bouton","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1615\/CritRevNeurobiol.v10.i3-4.70","article-title":"A\u00a0functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders","volume":"10","author":"Charney","year":"1996","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.npp.1300655","article-title":"Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear","volume":"30","author":"Chhatwal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S1092852900020939","article-title":"Modulation of fear and anxiety by the endogenous cannabinoid system","volume":"12","author":"Chhatwal","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib8","first-page":"32","article-title":"Effective psychotherapies for posttraumatic stress disorder: a review and critique","volume":"14","author":"Cloitre","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib9","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1523\/JNEUROSCI.2246-05.2005","article-title":"Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction","volume":"25","author":"Corcoran","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.addbeh.2010.02.004","article-title":"Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression","volume":"35","author":"Cornelius","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.brat.2007.10.003","article-title":"Optimizing inhibitory learning during exposure therapy","volume":"46","author":"Craske","year":"2008","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-cycloserine on extinction: translation from preclinical to clinical work","volume":"60","author":"Davis","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib14","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.neuroscience.2008.05.005","article-title":"Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction","volume":"154","author":"de Oliveira Alvares","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuroimage.2007.11.042","article-title":"Neural correlates of unconditioned response diminution during Pavlovian conditioning","volume":"40","author":"Dunsmoor","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib16","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib17","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I\/NP)","author":"First","year":"2002"},{"issue":"Suppl. 5","key":"10.1016\/j.neuropharm.2012.06.063_bib18","first-page":"43","article-title":"Psychosocial treatment of posttraumatic stress disorder","volume":"61","author":"Foa","year":"2000","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.molmed.2003.09.005","article-title":"Anandamide hydrolysis: a new target for anti-anxiety drugs?","volume":"9","author":"Gaetani","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0074-7742(09)85005-8","article-title":"The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs","volume":"85","author":"Gaetani","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.pbb.2003.12.019","article-title":"Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test","volume":"77","author":"Genn","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1176\/appi.ajp.2011.11040557","article-title":"The study of fear extinction: implications for anxiety disorders","volume":"168","author":"Graham","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drugalcdep.2009.06.019","article-title":"Altered affective response in marijuana smokers: an FMRI study","volume":"105","author":"Gruber","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpsychires.2006.05.006","article-title":"A\u00a0randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear","volume":"41","author":"Guastella","year":"2007","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.brat.2006.07.005","article-title":"A\u00a0randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans","volume":"45","author":"Guastella","year":"2007","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A\u00a0randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib27","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/cercor\/bhq253","article-title":"Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear","volume":"21","author":"Hartley","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2005.10.006","article-title":"Extinction in human fear conditioning","volume":"60","author":"Hermans","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib30","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.brat.2007.06.006","article-title":"Enhancing exposure-based therapy from a translational research perspective","volume":"45","author":"Hofmann","year":"2007","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cpr.2007.04.009","article-title":"Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders","volume":"28","author":"Hofmann","year":"2008","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tips.2009.10.003","article-title":"Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders\u2013the case of yohimbine","volume":"31","author":"Holmes","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib33","series-title":"Cannabinoid Receptor Signaling Cannabinoids","first-page":"53","author":"Howlett","year":"2005"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1176\/appi.ajp.2009.09071074","article-title":"How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD","volume":"167","author":"Jovanovic","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib35","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1523\/JNEUROSCI.2021-06.2006","article-title":"Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network","volume":"26","author":"Kalisch","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib36","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1523\/JNEUROSCI.0153-06.2006","article-title":"Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes","volume":"26","author":"Kamprath","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pbb.2011.01.009","article-title":"The use of cognitive enhancers in animal models of fear extinction","volume":"99","author":"Kaplan","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(98)00264-0","article-title":"Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users","volume":"63","author":"Kirk","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib39","doi-asserted-by":"crossref","unstructured":"LaBar, K.S., LeDoux, J.E., Spencer, D.D., Phelps, E.A., 1995. Impaired fear conditioning following unilateral temporal lobectomy in humans. J. Neurosci. 15, 6846\u20136855.","DOI":"10.1523\/JNEUROSCI.15-10-06846.1995"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0896-6273(00)80475-4","article-title":"Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study","volume":"20","author":"LaBar","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2007.09.006","article-title":"The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction","volume":"56","author":"Lafenetre","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"117","author":"Ledgerwood","year":"2003","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1037\/0735-7044.118.3.505","article-title":"D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement","volume":"118","author":"Ledgerwood","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2005.01.023","article-title":"D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction","volume":"57","author":"Ledgerwood","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib45","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1101\/lm.1081908","article-title":"Chronic cannabinoid administration in\u00a0vivo compromises extinction of fear memory","volume":"15","author":"Lin","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/lm.217006","article-title":"Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle","volume":"13","author":"Lin","year":"2006","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cercor\/bhn075","article-title":"The role of prefrontal cortex CB1 receptors in the modulation of fear memory","volume":"19","author":"Lin","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12035-007-8004-x","article-title":"The endocannabinoid system and extinction learning","volume":"36","author":"Lutz","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib49","series-title":"Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System Cannabinoids","first-page":"299","author":"Mackie","year":"2005"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1469-8986.2005.00302.x","article-title":"Context modulation of memory for fear extinction in humans","volume":"42","author":"Milad","year":"2005","journal-title":"Psychophysiology"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib52","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2009.06.026","article-title":"Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder","volume":"66","author":"Milad","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib53","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1073\/pnas.0502441102","article-title":"Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory","volume":"102","author":"Milad","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nature01138","article-title":"Neurons in medial prefrontal cortex signal memory for fear extinction","volume":"420","author":"Milad","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.psych.121208.131631","article-title":"Fear extinction as a model for translational neuroscience: ten years of progress","volume":"63","author":"Milad","year":"2012","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopsycho.2006.01.008","article-title":"Fear extinction in rats: implications for human brain imaging and anxiety disorders","volume":"73","author":"Milad","year":"2006","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib57","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2006.10.011","article-title":"Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert","volume":"62","author":"Milad","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.neuroscience.2010.04.030","article-title":"The influence of gonadal hormones on conditioned fear extinction in healthy humans","volume":"168","author":"Milad","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib59","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.mp.4001939","article-title":"Mechanisms of fear extinction","volume":"12","author":"Myers","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib60","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A\u00a0meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.nmd.0000253843.70149.9a","article-title":"A\u00a0meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders","volume":"195","author":"Norton","year":"2007","journal-title":"J.\u00a0Nerv. Ment. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tics.2005.03.010","article-title":"The cognitive control of emotion","volume":"9","author":"Ochsner","year":"2005","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1037\/0021-843X.109.2.290","article-title":"De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder","volume":"109","author":"Orr","year":"2000","journal-title":"J.\u00a0Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib64","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nlm.2008.04.003","article-title":"Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats","volume":"90","author":"Pamplona","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00213-006-0514-0","article-title":"The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats","volume":"188","author":"Pamplona","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib66","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.nlm.2005.01.001","article-title":"Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats","volume":"83","author":"Parnas","year":"2005","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib67","series-title":"Pharmacological Actions of Cannabinoids Cannabinoids","first-page":"1","author":"Pertwee","year":"2005"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib68","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","article-title":"Cannabinoid modulation of amygdala reactivity to social signals of threat in humans","volume":"28","author":"Phan","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib69","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuron.2004.08.042","article-title":"Extinction learning in humans: role of the amygdala and vmPFC","volume":"43","author":"Phelps","year":"2004","journal-title":"Neuron"},{"issue":"Suppl. 17","key":"10.1016\/j.neuropharm.2012.06.063_bib70","first-page":"47","article-title":"Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging","volume":"62","author":"Pitman","year":"2001","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib71","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.janxdis.2009.01.001","article-title":"Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation","volume":"23","author":"Powers","year":"2009","journal-title":"J.\u00a0Anxiety Disord."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib72","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.conb.2006.07.004","article-title":"Prefrontal involvement in the regulation of emotion: convergence of rat and human studies","volume":"16","author":"Quirk","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biopsych.2006.03.010","article-title":"Prefrontal mechanisms in extinction of conditioned fear","volume":"60","author":"Quirk","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib74","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1523\/JNEUROSCI.23-25-08800.2003","article-title":"Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons","volume":"23","author":"Quirk","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.npp.1301555","article-title":"Neural mechanisms of extinction learning and retrieval","volume":"33","author":"Quirk","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib76","article-title":"Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect","author":"Rabinak","year":"2011","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2006.06.004","article-title":"Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research\u2013past, present, and future","volume":"60","author":"Rauch","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib78","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib79","first-page":"235","article-title":"Mechanisms underlying spontaneous recovery in autoshaping","volume":"16","author":"Robbins","year":"1990","journal-title":"J.\u00a0Exp. Psychol.: Animal Behav. Process."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib80","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1111\/j.1460-9568.2007.05861.x","article-title":"The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats","volume":"26","author":"Roche","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1037\/0033-295X.105.2.325","article-title":"From normal fear to pathological anxiety","volume":"105","author":"Rosen","year":"1998","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature08637","article-title":"Preventing the return of fear in humans using reconsolidation update mechanisms","volume":"463","author":"Schiller","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(86)90003-X","article-title":"Antianxiety effect of cannabis: involvement of central benzodiazepine receptors","volume":"21","author":"Sethi","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib84","first-page":"25","article-title":"Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines","volume":"14","author":"Stein","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib85","first-page":"CD002795","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","author":"Stein","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib86","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YIC.0b013e32819f8480","article-title":"D-cycloserine does not enhance exposure-response prevention therapy in obsessive\u2013compulsive disorder","volume":"22","author":"Storch","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib87","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1523\/JNEUROSCI.5491-03.2004","article-title":"Memory reconsolidation and extinction have distinct temporal and biochemical signatures","volume":"24","author":"Suzuki","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0005-7967(01)00024-9","article-title":"Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout","volume":"40","author":"van Minnen","year":"2002","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1020177023209","article-title":"Fear activation and habituation patterns as early process predictors of response to prolonged exposure treatment in PTSD","volume":"15","author":"van Minnen","year":"2002","journal-title":"J.\u00a0Trauma Stress"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib90","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00213-004-2121-2","article-title":"Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice","volume":"179","author":"Varvel","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib91","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.npp.1301224","article-title":"Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task","volume":"32","author":"Varvel","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib92","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00008877-200509000-00007","article-title":"Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods","volume":"16","author":"Viveros","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib93","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","article-title":"Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans","volume":"161","author":"Wachtel","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.063_bib94","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A\u00a0role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.063_bib96","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.biopsych.2011.05.016","article-title":"Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats","volume":"70","author":"Zeidan","year":"2011","journal-title":"Biol. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T17:44:57Z","timestamp":1561916697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":96,"alternative-id":["S0028390812003371"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.063","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}